SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Larissa Vuitika, biologist, works during the virus inactivation process on March 24, 2020 in Belo Horizonte, Brazil. (Photo: Pedro Vilela/Getty Images)
International Coalition of Public Health Advocates Denounces Any Big Pharma Effort to Profiteer Off Covid-19 Treatments, Vaccines
"Health is a human right. Medical knowledge is a public good. No one should be left behind."
Apr 24, 2020
More than 250 public interest groups on Thursday urged global cooperation as scientists around the world work to develop treatments and a vaccine for the coronavirus, warning against "nationalistic" or monopoly-based responses to the pandemic which has spread to at least 177 countries and killed more than 186,000 people worldwide.
Public Citizen was joined by 254 groups including Doctors Without Borders, Oxfam, and Indivisible in calling on world governments to abide by several key principles as they search for medical breakthroughs to treat people diagnosed with COVID-19, the disease caused by the new coronavirus, and for a vaccine.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism." --254 public interest groups
"Open science, ramped-up manufacturing, fair pricing, and sharing of technology" must guide all efforts to develop effective treatments, the groups wrote--rather than secrecy and competition between countries.
"There is a grave danger that research efforts will be stymied and access for many patients to COVID-19 treatments and vaccines will be delayed by limited manufacturing capacity, commercial secrecy, and monopolies on key medical technologies, as well as by hostility to global cooperation," said Public Citizen in a statement.
Last month, the New York Times reported that efforts to combat the virus have become a "global arms race," with "China, Europe, and the United States...[setting] off at a sprint to become the first to produce a vaccine" and President Donald Trump reportedly telling American pharmaceutical executives that a vaccine must be produced on U.S. soil to control the supply chain.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism," reads the open letter.
The groups urged pharmaceutical companies and governments to commit to following four basic principles:
- Innovation for all, with technology owners committing patents, trade secrets, know-how, cell lines, copyright, software, data, and all other relevant intellectual property to the public domain
- Access for all, ensuring diagnostics, treatments, devices, vaccines, and personal protective equipment are priced fairly and affordably to healthcare payers and are free to the public at the point of care in all countries.
- Solidarity and global cooperation, including coordination with the World Health Organization to organize platforms for the public sharing of data and intellectual property to rapidly scale-up production and mitigate shortages.
- Good governance and transparency, with funders and technology developers ensuring that costs related to research, manufacturing, and pricing are published transparently.
The letter comes a month after a pressure campaign led by Public Citizen forced the drug manufacturer Gilead Sciences to withdraw a monopoly claim for remdesivir, a drug which is being tested as a possible treatment for COVID-19.
The drug's status as an "orphan drug," usually reserved for medications that treat very rare diseases, would have limited access for many patients.
"Health is a human right. Medical knowledge is a public good," wrote the groups on Thursday. "No one should be left behind."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
More than 250 public interest groups on Thursday urged global cooperation as scientists around the world work to develop treatments and a vaccine for the coronavirus, warning against "nationalistic" or monopoly-based responses to the pandemic which has spread to at least 177 countries and killed more than 186,000 people worldwide.
Public Citizen was joined by 254 groups including Doctors Without Borders, Oxfam, and Indivisible in calling on world governments to abide by several key principles as they search for medical breakthroughs to treat people diagnosed with COVID-19, the disease caused by the new coronavirus, and for a vaccine.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism." --254 public interest groups
"Open science, ramped-up manufacturing, fair pricing, and sharing of technology" must guide all efforts to develop effective treatments, the groups wrote--rather than secrecy and competition between countries.
"There is a grave danger that research efforts will be stymied and access for many patients to COVID-19 treatments and vaccines will be delayed by limited manufacturing capacity, commercial secrecy, and monopolies on key medical technologies, as well as by hostility to global cooperation," said Public Citizen in a statement.
Last month, the New York Times reported that efforts to combat the virus have become a "global arms race," with "China, Europe, and the United States...[setting] off at a sprint to become the first to produce a vaccine" and President Donald Trump reportedly telling American pharmaceutical executives that a vaccine must be produced on U.S. soil to control the supply chain.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism," reads the open letter.
The groups urged pharmaceutical companies and governments to commit to following four basic principles:
- Innovation for all, with technology owners committing patents, trade secrets, know-how, cell lines, copyright, software, data, and all other relevant intellectual property to the public domain
- Access for all, ensuring diagnostics, treatments, devices, vaccines, and personal protective equipment are priced fairly and affordably to healthcare payers and are free to the public at the point of care in all countries.
- Solidarity and global cooperation, including coordination with the World Health Organization to organize platforms for the public sharing of data and intellectual property to rapidly scale-up production and mitigate shortages.
- Good governance and transparency, with funders and technology developers ensuring that costs related to research, manufacturing, and pricing are published transparently.
The letter comes a month after a pressure campaign led by Public Citizen forced the drug manufacturer Gilead Sciences to withdraw a monopoly claim for remdesivir, a drug which is being tested as a possible treatment for COVID-19.
The drug's status as an "orphan drug," usually reserved for medications that treat very rare diseases, would have limited access for many patients.
"Health is a human right. Medical knowledge is a public good," wrote the groups on Thursday. "No one should be left behind."
More than 250 public interest groups on Thursday urged global cooperation as scientists around the world work to develop treatments and a vaccine for the coronavirus, warning against "nationalistic" or monopoly-based responses to the pandemic which has spread to at least 177 countries and killed more than 186,000 people worldwide.
Public Citizen was joined by 254 groups including Doctors Without Borders, Oxfam, and Indivisible in calling on world governments to abide by several key principles as they search for medical breakthroughs to treat people diagnosed with COVID-19, the disease caused by the new coronavirus, and for a vaccine.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism." --254 public interest groups
"Open science, ramped-up manufacturing, fair pricing, and sharing of technology" must guide all efforts to develop effective treatments, the groups wrote--rather than secrecy and competition between countries.
"There is a grave danger that research efforts will be stymied and access for many patients to COVID-19 treatments and vaccines will be delayed by limited manufacturing capacity, commercial secrecy, and monopolies on key medical technologies, as well as by hostility to global cooperation," said Public Citizen in a statement.
Last month, the New York Times reported that efforts to combat the virus have become a "global arms race," with "China, Europe, and the United States...[setting] off at a sprint to become the first to produce a vaccine" and President Donald Trump reportedly telling American pharmaceutical executives that a vaccine must be produced on U.S. soil to control the supply chain.
"There is real danger that access to medical breakthroughs addressing COVID-19 will be restricted by nation, by price, by limited production and fragmented supply lines, and by exclusivity and commercial confidentiality. We must prevent this--and help change medical innovation, health, and nationalism," reads the open letter.
The groups urged pharmaceutical companies and governments to commit to following four basic principles:
- Innovation for all, with technology owners committing patents, trade secrets, know-how, cell lines, copyright, software, data, and all other relevant intellectual property to the public domain
- Access for all, ensuring diagnostics, treatments, devices, vaccines, and personal protective equipment are priced fairly and affordably to healthcare payers and are free to the public at the point of care in all countries.
- Solidarity and global cooperation, including coordination with the World Health Organization to organize platforms for the public sharing of data and intellectual property to rapidly scale-up production and mitigate shortages.
- Good governance and transparency, with funders and technology developers ensuring that costs related to research, manufacturing, and pricing are published transparently.
The letter comes a month after a pressure campaign led by Public Citizen forced the drug manufacturer Gilead Sciences to withdraw a monopoly claim for remdesivir, a drug which is being tested as a possible treatment for COVID-19.
The drug's status as an "orphan drug," usually reserved for medications that treat very rare diseases, would have limited access for many patients.
"Health is a human right. Medical knowledge is a public good," wrote the groups on Thursday. "No one should be left behind."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.